● Recruiting

A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

Condition: Neurotrophic Keratitis · Sponsor: TearSolutions, Inc.

PhasePhase 2

Planned participants54

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Objective: To evaluate the safety of Lacripep 4 μM Ophthalmic Solution and its effect on the ocular surface, visual function, corneal sensitivity, and quality of life of subjects with Stage 1 NK.

This description comes directly from the study's public registry record.

Talk to the study team

Marc Odrich, MD · 646.249.2800 · modrich@tearsolutions.com

Michelle Carpenter · mcarpenter@rpspharma.com

Always discuss trial participation with your own doctor first.

Locations (3)

Midwest Cornea Associates	Carmel, Indiana, United States	Recruiting
Minnesota Eye Consultants	Minneapolis, Minnesota, United States	Recruiting
Ophthalmology Associates	St Louis, Missouri, United States	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07568730